Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era
- 29 October 2023
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 30 (5) , 694-700
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (UL1TR000445)
- National Institutes of Health
- American Heart Association Inc (929347)
This publication has 39 references indexed in Scilit:
- Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional studyBMC Infectious Diseases, 2011
- Diverse morphologic manifestations of cardiac allograft vasculopathy: A pathologic study of 64 allograft heartsThe Journal of Heart and Lung Transplantation, 2011
- Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patientsAIDS, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- The Chemokine and Chemokine Receptor Profile of Infiltrating Cells in the Wall of Arteries With Cardiac Allograft Vasculopathy Is Indicative of a Memory T–Helper 1 ResponseCirculation, 2006
- Assessment of Cardiac Allograft Vasculopathy Late After Heart Transplantation: When Is Coronary Angiography Necessary?The Journal of Heart and Lung Transplantation, 2006
- Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrenceJournal of Hepatology, 2006
- Multicenter Intravascular Ultrasound Validation Study Among Heart Transplant RecipientsJACC, 2005
- Intravascular Ultrasound Evidence of Angiographically Silent Progression in Coronary Atherosclerosis Predicts Long-Term Morbidity and Mortality After Cardiac TransplantationJACC, 2005
- Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantationThe Journal of Heart and Lung Transplantation, 2004